Literature DB >> 19251111

RNA interference against aldehyde dehydrogenase-2: development of tools for alcohol research.

Gabriel Cortínez1, Amalia Sapag, Yedy Israel.   

Abstract

Liver alcohol dehydrogenase oxidizes ethanol to acetaldehyde, which is further oxidized to acetate by aldehyde dehydrogenase-2 (ALDH2*1). Individuals who carry a low-activity ALDH2 (ALDH2*2) display high blood acetaldehyde levels after ethanol consumption, which leads to dysphoric effects, such as facial flushing, nausea, dizziness, and headache ("Asian alcohol phenotype"), which result in an aversion to alcohol and protection against alcohol abuse and alcoholism. Mimicking this phenotype may reduce alcohol consumption in alcoholics. RNA interference (RNAi) is a cell process in which a short interfering RNA (siRNA) of 21-25 bp guides the degradation of a complementary target mRNA. Thus, siRNAs may be useful in mimicking the Asian phenotype by inhibiting ALDH2 gene expression. We determined the inhibitory effect of three chemically synthesized siRNAs targeted against rat ALDH2 mRNA in human embryonic kidney cells (HEK-293 cell lines) transfected with a plasmid carrying the rat ALDH2 cDNA. Two of the three siRNAs were active, yielding a 65-75% reduction of ALDH2 activity. Based on the most promising siRNA sequence, three short hairpin RNA (shRNA) genes driven by the human U6 RNA promoter were designed and cloned in a plasmid. After transfection of HEK-293 cells, one of the genes was shown to be active, yielding a 50% reduction of ALDH2 activity. This effect is consistent with a 50% reduction in ALDH2 mRNA, whereas neither beta-actin mRNA nor the interferon-inducible transmembrane protein-1 mRNA levels were affected. This study describes chemically synthesized siRNAs and an endogenously synthesized shRNA, which reduce ALDH2 activity and constitute tools that should be of value for further alcohol research.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19251111     DOI: 10.1016/j.alcohol.2008.12.007

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  6 in total

Review 1.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Seong-Ho Yoo; Bong-Jo Kim; Sangmee A Jo; Inho Jo; Kwan-Hoon Moon
Journal:  J Proteomics       Date:  2011-05-15       Impact factor: 4.044

2.  AAV Gene Therapy for Alcoholism: Inhibition of Mitochondrial Aldehyde Dehydrogenase Enzyme Expression in Hepatoma Cells.

Authors:  Anamaria C Sanchez; Chengwen Li; Barbara Andrews; Juan A Asenjo; R Jude Samulski
Journal:  Hum Gene Ther       Date:  2017-06-02       Impact factor: 5.695

3.  A comparison of CRISPR/Cas9 and siRNA-mediated ALDH2 gene silencing in human cell lines.

Authors:  Fei Wang; Tao Guo; Hongmei Jiang; Ruobi Li; Ting Wang; Ni Zeng; Guanghui Dong; Xiaowen Zeng; Daochuan Li; Yongmei Xiao; Qiansheng Hu; Wen Chen; Xiumei Xing; Qing Wang
Journal:  Mol Genet Genomics       Date:  2018-01-30       Impact factor: 3.291

4.  Targeting liver aldehyde dehydrogenase-2 prevents heavy but not moderate alcohol drinking.

Authors:  Adrien Guillot; Tianyi Ren; Tony Jourdan; Robert J Pawlosky; Elaine Han; Seung-Jin Kim; Li Zhang; George F Koob; Bin Gao
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-02       Impact factor: 11.205

5.  Gene Therapy Correction of Aldehyde Dehydrogenase 2 Deficiency.

Authors:  Yuki Matsumura; Katie M Stiles; Jasmine Reid; Esther Z Frenk; Samantha Cronin; Odelya E Pagovich; Ronald G Crystal
Journal:  Mol Ther Methods Clin Dev       Date:  2019-08-26       Impact factor: 6.698

6.  Isoflurane preconditioning confers cardioprotection by activation of ALDH2.

Authors:  Xiao-E Lang; Xiong Wang; Ke-Rang Zhang; Ji-Yuan Lv; Jian-Hua Jin; Qing-Shan Li
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.